BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by StockNews.com
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has ...
Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
By Maggie Fick LONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on ...
Pharma firms ‘disappointed and concerned’ by lack of State support for campaign against EU reforms
Correspondence seen by The Irish Times shows several big pharma companies, such as Pfizer, MSD, Novo Nordisk and AstraZeneca, ...
Inside the pharma industry’s lobbying campaign to water down reforms
Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...
HC Wainwright Issues Pessimistic Forecast for REGENXBIO (NASDAQ:RGNX) Stock Price
REGENXBIO (NASDAQ:RGNX – Free Report) had its price target cut by HC Wainwright from $36.00 to $34.00 in a research report ...
Morepen Labs shares skyrocket 12% on rolling out 'Empamore'; details here
The uptick in the Morepen Labs share came after the company announced that it has rolled out ‘Empamore.’ Empamore is used to ...